Chemoenzymatic glyco-engineering of monoclonal antibodies

Methods in Molecular Biology

Volumn 1321, Issue , 2015, Pages 375-387

  Giddens, John P ^a   Wang, Lai Xi ^a  

^a NONE

Author keywords

ADCC; Chemoenzymatic synthesis; Fc glycosylation; Glyco engineering; Monoclonal antibody; Transglycosylation

Indexed keywords

IMMUNOGLOBULIN G; RITUXIMAB;

ARTICLE; CATALYST; DEGLYCOSYLATION; EGG YOLK; ELECTROSPRAY MASS SPECTROMETRY; ENZYME ENGINEERING; GENE EXPRESSION SYSTEM; IMMUNOGLOBULIN BLOOD LEVEL; LIQUID CHROMATOGRAPHY; NONHUMAN; PRIORITY JOURNAL; SIALYLATION; WILD TYPE;

EID: 84957369935     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-2760-9_25     Document Type: Article

References (18)

1. Adams GP, Weiner LM (2005) Monoclonal antibody therapy of cancer. Nat Biotechnol 23: 1147–1157
2. Hogarth PM, Pietersz GA (2012) Fc receptortargeted therapies for the treatment of inflammation, cancer and beyond. Nat Rev Drug Discov 11:311–331
3. Jeffery R (2005) Glycosylation of recombinant antibody therapeutics. Biotechnol Prog 21: 11–16
4. Jeffery R (2009) Glycosylation as a strategy to improve antibody-based therapeutics. Nat Rev Drug Discov 8:226–234
5. Kaneko Y, Nimmerjahn F, Ravetch JV (2006) Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science 313: 670–673
6. Anthony RM, Nimmerjahn F, Ashline DJ et al (2008) Recapitulation of IVIG antiinflammatory activity with a recombinant IgG Fc. Science 320:373–376
7. Karsten CM, Pandey MK, Figge J et al (2012) Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcgammaRIIB and dectin-1. Nat Med 18: 1401–1406
8. Frenzel A, Hust M, Schirrmann T (2013) Expression of recombinant antibodies. Front Immunol 4:217
9. Huang W, Giddens J, Fan SQ et al (2012) Chemoenzymatic glyco-engineering of intact IgG antibodies for gain of functions. J Am Chem Soc 134:12308–12318
10. Zou G, Ochiai H, Huang W et al (2011) Chemoenzymatic synthesis and Fcgamma receptor binding of homogeneous glycoforms of antibody Fc domain. Presence of a bisecting sugar moiety enhances the affinity of Fc to FcgammaIIIa receptor. J Am Chem Soc 133:18975–18991
11. Wei Y, Li C, Huang W et al (2008) Glycoengineering of human IgG1-Fc through combined yeast expression and in vitro chemoenzymatic glycosylation. Biochemistry 47: 10294–10304
12. Collin M, Olsen A (2001) EndoS, a novel secreted protein from Streptococcus pyogenes with endoglycosidase activity on human IgG. EMBO J 20:3046–3055
13. Wang LX, Amin MN (2014) Chemical and chemoenzymatic synthesis of glycoproteins for deciphering functions. Chem Biol 21:51–66
14. Collin M, Svensson MD, Sjoholm AG et al (2002) EndoS and SpeB from Streptococcus pyogenes inhibit immunoglobulin-mediated opsonophagocytosis. Infect Immun 70:6646–6651
15. Seko A, Koketsu M, Nishizono M et al (1997) Occurrence of a sialylglycopeptide and free sialylglycans in hen’s egg yolk. Biochim Biophys Acta 1335:23–32
16. Umekawa M, Huang W, Li B et al (2008) Mutants of Mucor hiemalis endo-beta-Nacetylglucosaminidase show enhanced transglycosylation and glycosynthase-like activities. J Biol Chem 283:4469–4479
17. Noguchi M, Tanaka T, Gyakushi H et al (2009) Efficient synthesis of sugar oxazolines from unprotected N-acetyl-2-amino sugars by using chloroformamidinium reagent in water. J Org Chem 74:2210–2212
18. Huang W, Yang Q, Umekawa M et al (2010) Arthrobacter endo-beta-N- acetylglucosaminidase shows transglycosylation activity on complex-type N-glycan oxazolines: one-pot conversion of ribonuclease B to sialylated ribonuclease C. Chem Bio Chem 11:1350–1355